Anaesthetic Drugs and Pain Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL ANAESTHETIC DRUGS AND PAIN DRUGS INDUSTRY

2.1 Summary about Anaesthetic Drugs and Pain Drugs Industry

2.2 Anaesthetic Drugs and Pain Drugs Market Trends

2.2.1 Anaesthetic Drugs and Pain Drugs Production & Consumption Trends

2.2.2 Anaesthetic Drugs and Pain Drugs Demand Structure Trends

2.3 Anaesthetic Drugs and Pain Drugs Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Anaesthetic Drugs

4.2.2 Pain Drugs

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital

4.3.2 Clinic

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Anaesthetic Drugs

5.2.2 Pain Drugs

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital

5.3.2 Clinic

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Anaesthetic Drugs

6.2.2 Pain Drugs

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital

6.3.2 Clinic

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Anaesthetic Drugs

7.2.2 Pain Drugs

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital

7.3.2 Clinic

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Anaesthetic Drugs

8.2.2 Pain Drugs

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital

8.3.2 Clinic

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Anaesthetic Drugs

9.2.2 Pain Drugs

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital

9.3.2 Clinic

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 AstraZeneca

10.1.2 Endo International

10.1.3 Johnson & Johnson

10.1.4 Pfizer

10.1.5 Purdue Pharma

10.1.6 Baxter

10.1.7 Bayer AG

10.1.8 Merck

10.1.9 Novartis

10.2 Anaesthetic Drugs and Pain Drugs Sales Date of Major Players (2017-2020e)

10.2.1 AstraZeneca

10.2.2 Endo International

10.2.3 Johnson & Johnson

10.2.4 Pfizer

10.2.5 Purdue Pharma

10.2.6 Baxter

10.2.7 Bayer AG

10.2.8 Merck

10.2.9 Novartis

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Anaesthetic Drugs and Pain Drugs Product Type Overview

2.Table Anaesthetic Drugs and Pain Drugs Product Type Market Share List

3.Table Anaesthetic Drugs and Pain Drugs Product Type of Major Players

4.Table Brief Introduction of AstraZeneca

5.Table Brief Introduction of Endo International

6.Table Brief Introduction of Johnson & Johnson

7.Table Brief Introduction of Pfizer

8.Table Brief Introduction of Purdue Pharma

9.Table Brief Introduction of Baxter

10.Table Brief Introduction of Bayer AG

11.Table Brief Introduction of Merck

12.Table Brief Introduction of Novartis

13.Table Products & Services of AstraZeneca

14.Table Products & Services of Endo International

15.Table Products & Services of Johnson & Johnson

16.Table Products & Services of Pfizer

17.Table Products & Services of Purdue Pharma

18.Table Products & Services of Baxter

19.Table Products & Services of Bayer AG

20.Table Products & Services of Merck

21.Table Products & Services of Novartis

22.Table Market Distribution of Major Players

23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

25.Table Global Anaesthetic Drugs and Pain Drugs Market Forecast (Million USD) by Region 2021f-2026f

26.Table Global Anaesthetic Drugs and Pain Drugs Market Forecast (Million USD) Share by Region 2021f-2026f

27.Table Global Anaesthetic Drugs and Pain Drugs Market Forecast (Million USD) by Demand 2021f-2026f

28.Table Global Anaesthetic Drugs and Pain Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f